Factor V Leiden prevalence in venous thromboembolism patients

Chest

Volumn 111, Issue 6, 1997, Pages 1603-1606

  Leroyer, Christophe ^a   Mercier, Bernard ^a   Escoffre, Martine ^a   Férec, Claude ^a   Mottier, Dominique ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Embolism; Factor V; Pulmonary; Risk factor; thrombophilia; Thrombosis, vein

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; POINT MUTATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0030954466     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.6.1603     Document Type: Article

References (14)

1. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67
2. Greengard JS, Eichinger S, Griffin JH, et al. Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg → Glu mutation in the gene for factor V. N Engl J Med 1994; 331:1559-62
3. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90:1004-08
4. Koster T, Rosendaal FR, De Bonde H, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342:1503-06
5. Svensson PJ, Dahlbäck BD. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330:517-22
6. Legnani C, Palareti G, Biagi R, et al. Activated protein C resistance in deep-vein thrombosis. Lancet 1994; 343:541-42
7. Girolami A, Legnani C. Rosendaal F, Evaluation of activated protein C resistance in stored plasma. Lancet 1994; 343:1288-90
8. Desmarais S, de Moerloose P, Reber G, et al. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 1996; 347:1374-75
9. The PIOPED investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. JAMA 1990; 263:2753-59
10. Higuchi R. Simple and rapid preparation of samples for PCR. In: Erlish H, ed. PCR technology. New York: Stockton Press, 1989; 31-38
11. Martin F, Leroyer C, Oger E, et al. Deep venous thrombosis and associated pulmonary embolism. Rev Mal Respir 1995; 12:465-69
12. Rosendaal FR, Koster T, Vandenbrouke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden. Blood 1995; 85:1504-08
13. Ridker PM, Hennekens CH, Lindpainter K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332:912-17
14. Ridker PM, Miletich JP, Stampfer MJ, et al. Factor V Leiden and risks of recurrent idiopathic thromboembolism. Circulation 1995; 92:2800-02